BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5811101)

  • 1. Clinical evaluation of the effect of glyclopyramide in diabetes mellitus.
    Yamagata S; Goto Y; Oneda A; Kikuchi J; Toyota T
    Tohoku J Exp Med; 1969 Jun; 98(2):155-69. PubMed ID: 5811101
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

  • 4. [HB 419 (Glybenclamide) in the treatment of diabetes mellitus].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1969; 6(2):222-40. PubMed ID: 5397406
    [No Abstract]   [Full Text] [Related]  

  • 5. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.
    Hecht A; Gershberg H; Hulse M
    Metabolism; 1973 May; 22(5):723-33. PubMed ID: 4704717
    [No Abstract]   [Full Text] [Related]  

  • 9. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin-independent diabetes mellitus.
    Bricker LA; Mintz DH
    Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].
    Sil'nitskiĭ PA
    Probl Endokrinol (Mosk); 1968; 14(3):9-13. PubMed ID: 5734589
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus: the thin maturity-onset diabetic.
    Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
    [No Abstract]   [Full Text] [Related]  

  • 15. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glibornurid in treatment of diabetes mellitus].
    Rojszykowa E; Wrzesimski W
    Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
    Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
    Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.
    Raptis S; Pfeiffer EF
    Acta Diabetol Lat; 1972; 9(6):865-99. PubMed ID: 4197419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.